301 related articles for article (PubMed ID: 37560802)
1. Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy.
Shirley DA; Tornel W; Warren CA; Moonah S
Pediatrics; 2023 Sep; 152(3):. PubMed ID: 37560802
[TBL] [Abstract][Full Text] [Related]
2. An insight into
Thabit AK; Aljedaani HJ; Alghamdi RH; Badahdah RM; Lashkar MO; Alnajjar A
Expert Rev Gastroenterol Hepatol; 2023; 17(8):805-810. PubMed ID: 37480286
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Therapies for Clostridioides difficile Infection in Children.
Gonzales-Luna AJ; Carlson TJ; Garey KW
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S52-S57. PubMed ID: 34791393
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
Nelson RL; Suda KJ; Evans CT
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004610. PubMed ID: 28257555
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
6. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
Collins DA; Riley TV
Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
9. Frontiers in antibiotic alternatives for
Phanchana M; Harnvoravongchai P; Wongkuna S; Phetruen T; Phothichaisri W; Panturat S; Pipatthana M; Charoensutthivarakul S; Chankhamhaengdecha S; Janvilisri T
World J Gastroenterol; 2021 Nov; 27(42):7210-7232. PubMed ID: 34876784
[No Abstract] [Full Text] [Related]
10. Characteristics and management of children with Clostridioides difficile infection at a tertiary pediatric hospital in China.
Li X; Xiao F; Li Y; Hu H; Xiao Y; Xu Q; Li D; Yu G; Wang Y; Zhang T
Braz J Infect Dis; 2022; 26(4):102380. PubMed ID: 35753395
[TBL] [Abstract][Full Text] [Related]
11. Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children.
Sattler MM; Crews JD
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S27-S33. PubMed ID: 34791399
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation.
Duclaux-Loras R; Berthiller J; Ferroni A; Chardot C; Goulet O; Lacaille F; Norsa L
Transplantation; 2020 Jan; 104(1):197-200. PubMed ID: 31205257
[TBL] [Abstract][Full Text] [Related]
13. Ridinilazole: a novel therapy for Clostridium difficile infection.
Vickers RJ; Tillotson G; Goldstein EJ; Citron DM; Garey KW; Wilcox MH
Int J Antimicrob Agents; 2016 Aug; 48(2):137-43. PubMed ID: 27283730
[TBL] [Abstract][Full Text] [Related]
14. [Clostridioides difficile - New Insights and Therapy Recommendations].
Schönherr S; Jung L; Lübbert C
Dtsch Med Wochenschr; 2023 Jun; 148(12):752-758. PubMed ID: 37257477
[TBL] [Abstract][Full Text] [Related]
15. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
[TBL] [Abstract][Full Text] [Related]
16. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
van Prehn J; Reigadas E; Vogelzang EH; Bouza E; Hristea A; Guery B; Krutova M; Norén T; Allerberger F; Coia JE; Goorhuis A; van Rossen TM; Ooijevaar RE; Burns K; Scharvik Olesen BR; Tschudin-Sutter S; Wilcox MH; Vehreschild MJGT; Fitzpatrick F; Kuijper EJ;
Clin Microbiol Infect; 2021 Dec; 27 Suppl 2():S1-S21. PubMed ID: 34678515
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children.
Kociolek LK; Crews JD; Schwenk HT
Curr Opin Infect Dis; 2021 Oct; 34(5):527-532. PubMed ID: 34232137
[TBL] [Abstract][Full Text] [Related]
18. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
[TBL] [Abstract][Full Text] [Related]
19. Fidaxomicin for the treatment of
Skinner AM; Scardina T; Kociolek LK
Future Microbiol; 2020 Jul; 15(11):967-979. PubMed ID: 32715754
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of Clostridium difficile infection.
Dupont HL
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
